BioregulatorResearch
Taxorest
Also known as: Bronchial Extract Bioregulator
A Cytomax bronchial bioregulator for airway damage repair and chronic bronchitis treatment.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
Per bioregulator protocol
Administration
Oral capsule
Mechanism of Action
Bronchial mucosal peptide complex that restores airway integrity and clears chronic inflammatory damage.
Key Research Areas
bioregulatorbronchialairwaybronchitis
Frequently Asked Questions
What is Taxorest?▾
A Cytomax bronchial bioregulator for airway damage repair and chronic bronchitis treatment.
How does Taxorest work?▾
Bronchial mucosal peptide complex that restores airway integrity and clears chronic inflammatory damage.
What is the recommended dosage for Taxorest?▾
The typical research dosage is Per bioregulator protocol, administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Taxorest?▾
The half-life of Taxorest is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Taxorest FDA approved?▾
Taxorest is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Taxorest is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.